In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

抗体 亲和力成熟 细胞因子 生物 受体 体外 体细胞突变 免疫系统 免疫学 分子生物学 细胞生物学 B细胞 生物化学
作者
Stefan Steidl,Olaf Ratsch,Bodo Brocks,Manuela Dürr,Elisabeth Thomassen-Wolf
出处
期刊:Molecular Immunology [Elsevier]
卷期号:46 (1): 135-144 被引量:85
标识
DOI:10.1016/j.molimm.2008.07.013
摘要

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a KD of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the interaction of GM-CSF with the GM-CSF receptor alpha chain. As a consequence this leads to a blockade in signal transduction as measured by abolished STAT5 phosphorylation in the presence of GM-CSF and antibody. Due to its pro-inflammatory role GM-CSF has been implicated in the pathophysiology of inflammatory diseases like rheumatoid arthritis or asthma. Based on the mode of action described herein MOR04357 shows favourable antibody features as a potential drug candidate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
切咖啡发布了新的文献求助10
1秒前
τ涛完成签到,获得积分10
2秒前
勤奋元容完成签到,获得积分10
4秒前
M乐天应助DrW采纳,获得10
5秒前
6秒前
Hugo发布了新的文献求助10
7秒前
胡呵呵完成签到 ,获得积分10
8秒前
9秒前
科研小白完成签到 ,获得积分10
11秒前
L2000发布了新的文献求助10
11秒前
Wy发布了新的文献求助10
12秒前
恰恰完成签到,获得积分20
12秒前
科研通AI2S应助Libra采纳,获得10
14秒前
Owen应助太叔明辉采纳,获得10
15秒前
15秒前
zho应助xiaoxiao采纳,获得10
16秒前
恰恰发布了新的文献求助10
16秒前
TobyGarfielD完成签到 ,获得积分10
17秒前
桐桐应助asdfghjkl采纳,获得10
17秒前
小绵羊完成签到,获得积分20
18秒前
没有昵称完成签到,获得积分10
18秒前
yuiaa完成签到,获得积分10
19秒前
20秒前
可爱的函函应助铜眼科采纳,获得10
20秒前
20秒前
L2000发布了新的文献求助10
22秒前
海带完成签到 ,获得积分10
26秒前
三年H完成签到,获得积分10
26秒前
潇湘完成签到 ,获得积分10
26秒前
美满雨莲完成签到,获得积分10
29秒前
曾经的依风完成签到,获得积分10
29秒前
安东路完成签到,获得积分10
32秒前
Hugo完成签到,获得积分10
33秒前
18-Crown-6完成签到 ,获得积分10
34秒前
时生111发布了新的文献求助10
34秒前
sigarc发布了新的文献求助10
35秒前
fmx完成签到,获得积分10
35秒前
36秒前
不配.应助zho采纳,获得10
38秒前
不配.应助zho采纳,获得10
38秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
安全防范技术与工程 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2024 Medicinal Chemistry Reviews 400
Dictionary of socialism 350
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3193732
求助须知:如何正确求助?哪些是违规求助? 2842736
关于积分的说明 8040586
捐赠科研通 2506798
什么是DOI,文献DOI怎么找? 1339392
科研通“疑难数据库(出版商)”最低求助积分说明 638752
邀请新用户注册赠送积分活动 607452